Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells

Journal of Ethnopharmacology

Volumn 121, Issue 2, 2009, Pages 304-312

  Park, Sang Eun ^a   Park, Cheol ^b   Kim, Sun Hee ^a   Hossain, Mohammad Akbar ^a   Kim, Min Young ^a   Chung, Hae Young ^a   Son, Woo Sung ^c   Kim, Gi Young ^d   Choi, Yung Hyun ^b   Kim, Nam Deuk ^a  

^a Pusan National University   (South Korea)

^b Dong Eui University   (South Korea)

^c Pusan National University Yangsan   (South Korea)

^d Jeju National University   (South Korea)

Author keywords

Apoptosis; COX 2; Human leukemia cells; Red ginseng; Telomerase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACTIN; BETA CATENIN; CASPASE 3; CASPASE 8; CASPASE 9; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; FAS LIGAND; GINSENG EXTRACT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE C GAMMA1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P21; PROTEIN P53; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

AGAR GEL ELECTROPHORESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN EXPRESSION; PROTEIN FAMILY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, AGAR GEL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MEDICINE, KOREAN TRADITIONAL; MICROSCOPY, FLUORESCENCE; PANAX; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-MYC; TELOMERASE; U937 CELLS;

INTRACISTERNAL A-PARTICLES; PANAX GINSENG;

EID: 57949107902     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.10.038     Document Type: Article

References (54)

1. Autexier C., and Greider C.W. Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochemical Science 21 (1996) 387-391
2. Bae S.S., Perry D.K., Oh Y.S., Choi J.H., Galadari S.H., Ghayur T., Ryu S.H., Hannun Y.A., and Suh P.G. Proteolytic cleavage of phospholipase C-γ1 during apoptosis in Molt-4 cells. The FASEB Journal 14 (2000) 1083-1092
3. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.S., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
4. Brancolini C., Lazarevic D., Rodriguez J., and Schneider C. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin. The Journal of Cell Biology 139 (1997) 759-771
5. Cao Y., and Prescott S.M. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. Journal of Cell Physiology 190 (2002) 279-286
6. Chang S.H., Liu C.H., Conway R., Han D.K., Nithipatikom K., Trifan O.C., Lane T.F., and Hla T. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 591-596
7. Chen X., Zhang J., Fang Y., Zhao C., and Zhu Y. Ginsenoside Rg1 delays tert-butyl hydroperoxide-induced premature senescence in human WI-38 diploid fibroblast cells. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 63 (2008) 253-264
8. Choi S.H., Kang H.K., Im E.O., Kim Y.J., Bae Y.T., Choi Y.H., Lee K.H., Chung H.Y., Chang H.K., and Kim N.D. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids. International Journal of Oncology 17 (2000) 971-976
9. Choi S.H., Im E., Kang H.K., Lee J.H., Kwak H.S., Bae Y.T., Park H.J., and Kim N.D. Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells. Cancer Letters 227 (2005) 153-162
10. Chui C.H., Wong R.S., Cheng G.Y., Lau F.Y., Kok S.H., Cheng C.H., Cheung F., Tang W.K., Teo I.T., Chan A.S., and Tang J.C. Antiproliferative ability of a combination regimen of crocodile egg extract, wild radix ginseng and natural Ganoderma lucidum on acute myelogenous leukemia. Oncology Reports 16 (2006) 1313-1316
11. Darimont C., Zbinden I., Avanti O., Leone-Vautravers P., Giusti V., Burckhardt P., Pfeifer A.M., and Mace K. Reconstitution of telomerase activity combined with HPV-E7 expression allow human preadipocytes to preserve their differentiation capacity after immortalization. Cell Death and Differentiation 10 (2003) 1025-1031
12. Davydov M., and Krikorian A.D. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. Journal of Ethnopharmacology 72 (2000) 345-393
13. Deveraux Q.L., Leo E., Stennicke H.R., Welsh K., Salvesen G.S., and Reed J.C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. The EMBO Journal 18 (1999) 5242-5251
14. DuBois R.N., and Smalley W.E. Cyclooxygenase, NSAIDs, and colorectal cancer. Journal of Gastroenterology 31 (1996) 898-906
15. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
16. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
17. Eligini S., Barbieri S.S., Cavalca V., Camera M., Brambilla M., De Franceschi M., Tremoli E., and Colli S. Diversity and similarity in signalling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells. Cardiovascular Research 15 (2005) 683-693
18. Fujita H., Koshida K., and Keller E.T. Cyclooxygenase-2 promotes prostate cancer progression. The Prostate 53 (2002) 232-240
19. Gartel A.L., and Tyner A.L. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Molecular Cancer Therapeutics 1 (2002) 639-649
20. Gately S., and Kerbel R. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. Progress in Experimental Tumor Research 37 (2003) 179-192
21. Greider C.W., and Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43 (1985) 405-413
22. Hacker G. The morphology of apoptosis. Cell and Tissue Research 301 (2000) 5-17
23. Hahn W.C., Counter C.M., Lundbekrg A.S., Beijersbergen R.L., Brooks M.W., and Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 400 (1999) 464-468
24. Hahn W.C., Stewart S.A., Brooks M.W., York S.G., Eaton E., Kurachi A., Beijersbergen R.L., Knoll J.H., Meyerson M., and Weinberg R.A. Inhibition of telomerase limits the growth of human cancer cells. Nature Medicine 5 (1999) 1164-1170
25. Hahn W.C., and Meyerson M. Telomerase activation, cellular immortalization and cancer. Annual Medicine 33 (2000) 123-129
26. Helms S. Cancer prevention and therapeutics; Panax ginseng. Alternative Medicine Review 9 (2004) 259-274
27. Keum Y.S., Han S.S., Chun K.S., Park K.K., Park J.H., Lee S.K., and Surh Y.J. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutation Research 523-524 (2003) 75-85
28. Kim Y.J., Kwon H.C., Ko H., Park J.H., Kim H.Y., Yoo J.H., and Yang H.O. Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biological & Pharmaceutical Bulletin 31 (2008) 826-830
29. Kitts D.D., Popovich D.G., and Hu C. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells. Canadian Journal of Physiological Pharmacology 85 (2007) 1173-1183
30. Kondo S., Tanaka Y., Kondo Y., Hitomi M., Barnett G.H., Ishizaka Y., Liu J., Haqqi T., Nishiyama A., Villeponteau B., Cowell J.K., and Barna B.P. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation. The FASEB Journal 12 (1998) 801-811
31. Kyo S., Kanaya T., Takakura M., Tanaka M., Yamashita A., Inoue H., and Inoue M. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. International Journal of Cancer 80 (1999) 804-809
32. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., and Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371 (1994) 346-347
33. Liu C.H., Chang S.H., Narko K., Trifan O.C., Wu M.T., Smith E., Haudenschild C., Lane T.F., and Hla T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. The Journal of Biological Chemistry 276 (2001) 18563-18569
34. Liu Q., Chan S.T., and Mahendran R. Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines. Carcinogenesis 24 (2003) 637-642
35. Meric J.B., Rottey S., Olaussen K., Soria J.C., Khayat D., Rixe O., and Spano J.P. Cyclooxygenase-2 as a target for anticancer drug development. Critical Reviews in Oncology/Hematology 59 (2006) 51-64
36. Morin G.B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59 (1989) 521-529
37. Oh M., Choi Y.H., Choi S., Chung H., Kim K., Kim S.I., Kim D.K., and Kim N.D. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. International Journal of Oncology 14 (1999) 869-875
38. Oulton R., and Harrington L. Telomeres, telomerase, and cancer: life on the edge of genomic stability. Current Opinion in Oncology 12 (2000) 74-81
39. Pai R., Nakamura T., Moon W.S., and Tarnawski A.S. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. The FASEB Journal 17 (2003) 1640-1647
40. Park C., Jung J.H., Kim N.D., and Choi Y.H. Inhibition of cyclooxygenase-2 and telomerase activities in human leukemia cells by dideoxypetrosynol A, a polyacetylene from the marine sponge Petrosia sp. International Journal of Oncology 30 (2007) 291-298
41. Roy N., Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. The EMBO Journal 16 (1997) 6914-6925
42. Salomons G.S., Brady H.J., Verwijs-Janssen M., van den Berg J.D., Hart A.A., van den Berg H., Behrendt H., Hahlen K., and Smets L.A. The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. International Journal of Cancer 71 (1997) 959-965
43. Takaku T., Kameda K., Matsuura Y., Sekiya K., and Okuda H. Studies on insulin-like substances in Korean red ginseng. Planta Medica 56 (1990) 27-30
44. Takakura M., Kyo S., Kanaya T., Tanaka M., and Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Research 58 (1998) 1558-1561
45. Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M., and Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Research 59 (1999) 551-557
46. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., and Dixit V.M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA inhibitable protease that cleaves the death substrate poly(ADPribose) polymerase. Cell 81 (1995) 801-809
47. Walker P.R., and Sikorska M. New aspects of the mechanism of DNA fragmentation in apoptosis. Biochemistry and Cell Biology 75 (1997) 287-299
48. Wang D., and Dubois R.N. Cyclooxygenase-2: a potential target in breast cancer. Seminars in Oncology 31 (2004) 64-73
49. Wang J., Xie L.Y., Allan S., Beach D., and Hannon G.J. Myc activates telomerase. Genes & Development 12 (1998) 1769-1774
50. Williams C.S., Mann M., and DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18 (1999) 7908-7915
51. Xiaoguang C., Hongyan L., Xiaohong L., Zhaodi F., Yan L., Lihua T., and Rui H. Cancer chemopreventive and therapeutic activities of red ginseng. Journal of Ethnopharmacology 60 (1998) 71-78
52. Yee S.B., Song Y.S., Jeong S.H., Lee H.S., Seo S.Y., Kim J.H., Suh H., Kim N.D., and Yoo Y.H. A novel chenodeoxycholic derivative HS-1200 enhances radiation-induced apoptosis in MCF-7 cells. Oncology Reports 17 (2007) 919-923
53. Yu J., and Zhang L. The transcriptional targets of p53 in apoptosis control. Biochemical and Biophysical Research Communications 331 (2005) 851-858
54. Yun T.K. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutation Research 523-524 (2003) 63-74